Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety/Tolerability of Ragweed MATA MPL, a Randomized, Placebo-Controlled, Double-Blind Study

NCT00423787 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00423787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00423787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety/Tolerability of Ragweed MATA MPL, a Randomized, Placebo-Controlled, Double-Blind Study
Lead sponsor
Allergy Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
March 31, 2008
Enrollment
993 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity